Keywords: posts, healthy, increase, sales, earnings, excluding, alza
J&J posts healthy increase in sales and earnings, excluding Alza merger
Article | 19 July 2001
Johnson & Johnson has reported net earnings up 8.7% at $1.48 billion forthe second quarter of 2001, while earnings per share improved 9.1% to $0.48. The ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
